Cargando…
Hand, hip and knee osteoarthritis in a Norwegian population-based study - The MUST protocol
BACKGROUND: Knowledge about the prevalence and consequences of osteoarthritis (OA) in the Norwegian population is limited. This study has been designed to gain a greater understanding of musculoskeletal pain in the general population with a focus on clinically and radiologically confirmed OA, as wel...
Autores principales: | Østerås, Nina, Risberg, May Arna, Kvien, Tore K, Engebretsen, Lars, Nordsletten, Lars, Bruusgaard, Dag, Schjervheim, Unni-Berit, Haugen, Ida K, Hammer, Hilde Berner, Provan, Sella, Øiestad, Britt Elin, Semb, Anne Grete, Rollefstad, Silvia, Hagen, Kåre Birger, Uhlig, Till, Slatkowsky-Christensen, Barbara, Kjeken, Ingvild, Flugsrud, Gunnar, Grotle, Margreth, Sesseng, Sølve, Edvardsen, Hanne, Natvig, Bård |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704709/ https://www.ncbi.nlm.nih.gov/pubmed/23826721 http://dx.doi.org/10.1186/1471-2474-14-201 |
Ejemplares similares
-
Efficacy of strength and aerobic exercise on patient-reported outcomes and structural changes in patients with knee osteoarthritis: study protocol for a randomized controlled trial
por: Øiestad, Britt Elin, et al.
Publicado: (2013) -
The efficacy of strength or aerobic exercise on quality of life and knee function in patients with knee osteoarthritis. A multi-arm randomized controlled trial with 1-year follow-up
por: Øiestad, Britt Elin, et al.
Publicado: (2023) -
Multidisciplinary and multifaceted outpatient management of patients with osteoarthritis: protocol for a randomised, controlled trial
por: Moe, Rikke Helene, et al.
Publicado: (2010) -
Urate crystal deposition is associated with inflammatory markers and carotid artery pathology in patients with intercritical gout: results from the NOR-Gout study
por: Hammer, Hilde Berner, et al.
Publicado: (2022) -
The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab
por: Provan, Sella Aarrestad, et al.
Publicado: (2015)